Deletion of interferon-regulatory factor-1 results in cognitive impairment

被引:0
|
作者
Masaki Mogi
Jun Iwanami
Xiao-Li Wang
Kana Tsukuda
Harumi Kan-no
Hui-Yu Bai
Bao-Shuai Shan
Akinori Higaki
Li-Juan Min
Masatsugu Horiuchi
机构
[1] Ehime University,Department of Molecular Cardiovascular Biology and Pharmacology
[2] Graduate School of Medicine,undefined
来源
Hypertension Research | 2018年 / 41卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Interferon-regulatory factor (IRF)-1-dependent genes in neurons play a role in ischemic neuronal death; however, the roles of IRF-1 in dementia are not well investigated. Therefore, we assessed the effect of IRF-1 on cognitive function using a vascular cognitive impairment mouse model created by chronic cerebral hypoperfusion. Male 10-week-old C57BL/6 (wild-type; WT) and IRF-1-knockout (IRF-1KO) mice were used in this study. A chronic cerebral hypoperfusion mouse model was generated by bilateral common carotid artery stenosis (BCAS) treatment. After 6 weeks of BCAS, the mice were subjected to the Morris water maze test five times a day for 5 days. In the Morris water maze task, escape latency was significantly prolonged in sham-operated IRF-1KO mice compared with sham-operated WT mice. However, BCAS treatment cancelled such difference in spatial learning between WT and IRF-1KO mice. BCAS treatment decreased CBF, but no significant difference was observed between the two strains after BCAS. Sham-operated IRF-1KO mice showed a decrease in mRNA expression of caspase-1 and an increase in IRF-2 expression in the hippocampus. Expression of angiotensin II type 2 (AT2) receptor, which induces better cognitive function, is regulated by IRF-1; however, no obvious difference in AT2 receptor expression was observed between the two strains even after BCAS. These results suggest that IRF-1 has a protective effect on cognitive decline in a normal condition; however, there was no obvious effect on cognition after chronic cerebral hypoperfusion treatment.
引用
收藏
页码:809 / 816
页数:7
相关论文
共 50 条
  • [1] Deletion of interferon-regulatory factor-1 results in cognitive impairment
    Mogi, Masaki
    Iwanami, Jun
    Wang, Xiao-Li
    Tsukuda, Kana
    Kan-no, Harumi
    Bai, Hui-Yu
    Shan, Bao-Shuai
    Higaki, Akinori
    Min, Li-Juan
    Horiuchi, Masatsugu
    HYPERTENSION RESEARCH, 2018, 41 (10) : 809 - 816
  • [2] Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy
    Liang, Ji
    Piao, Yuji
    Henry, Verlene
    Tiao, Ningyi
    de Groot, John F.
    ONCOTARGET, 2015, 6 (31) : 31479 - 31492
  • [3] Interferon-gamma regulates the progression of neuroblastoma cells through interferon-regulatory factor-1
    Wang, Jing
    Xu, Junfeng
    Yang, Yingran
    Qiu, Youzheng
    Zhang, Shanshan
    Wang, Ning
    BIOCELL, 2024, 48 (09) : 1343 - 1353
  • [4] Changes in interferon-regulatory factor-1 mRNA levels after transient ischemia in rat brain
    Paschen, W
    Gissel, C
    Althausen, S
    Doutheil, J
    NEUROREPORT, 1998, 9 (14) : 3147 - 3151
  • [5] Cytokines induce expression of interferon-regulatory factor-1 (IRF-1) in insulin-producing cells
    Flodstrom, M
    Eizirik, DL
    DIABETOLOGIA, 1996, 39 : 384 - 384
  • [6] Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells
    Bowie, ML
    Dietze, EC
    Delrow, J
    Bean, GR
    Troch, MM
    Marjoram, RJ
    Seewaldt, VL
    ONCOGENE, 2004, 23 (54) : 8743 - 8755
  • [7] Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells
    Michelle L Bowie
    Eric C Dietze
    Jeffery Delrow
    Gregory R Bean
    Michelle M Troch
    Robin J Marjoram
    Victoria L Seewaldt
    Oncogene, 2004, 23 : 8743 - 8755
  • [8] A hyperactive mutant of interferon-regulatory factor 4
    Kang, Chol Ho
    Hartmann, Enno
    Menke, Lisa
    Staudenraus, Daniel
    Abass, El-Fadil
    Raifer, Hartmann
    Porapu, Alekya
    Camara, Baerbel
    Brustle, Anne
    Pinkenburg, Olaf
    Bieringer, Maria
    Lohoff, Michael
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (05) : 812 - 815
  • [9] Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice
    Reilly, Christopher M.
    Olgun, Selen
    Goodwin, David
    Gogal, Robert M., Jr.
    Santo, Arben
    Romesburg, Jason W.
    Ahmed, S. Ansar
    Gilkeson, Gary S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (05) : 1296 - 1308
  • [10] Interferon-regulatory factor-1 boosts bevacizumab cardiotoxicity by the vascular endothelial growth factor A/14-3-3γ axis
    Chen, Xuan-Ying
    Xie, Meng-Qi
    Huang, Wei-Lin
    Li, Wen-Juan
    Lv, Yan-Ni
    Peng, Xiao-Ping
    ESC HEART FAILURE, 2024, 11 (02): : 986 - 1000